HQH PE Ratio & Valuation, Is HQH Overvalued

Historical Valuation

abrdn Healthcare Investors (HQH) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of abrdn Healthcare Investors (HQH) is between -- to -- according to relative valuation method.

Relative Value

Fair Zone

-----

Current Price：17.69

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is abrdn Healthcare Investors (HQH) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

abrdn Healthcare Investors (HQH) has a current Price-to-Book (P/B) ratio of 0.77. Compared to its 3-year average P/B ratio of 0.84, the current P/B ratio is approximately -8.08% higher. Relative to its 5-year average P/B ratio of 0.84, the current P/B ratio is about -8.08% higher. abrdn Healthcare Investors (HQH) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 0.00%, the current FCF yield is approximately NaN% lower. Relative to its 5-year average FCF yield of 0.00%, the current FCF yield is about NaN% lower.

Performance Decomposition

AI Analysis

Market capitalization of HQH increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of HQH in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is HQH currently overvalued or undervalued?

What is abrdn Healthcare Investors (HQH) fair value?

HQH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of abrdn Healthcare Investors (HQH) is between to according to relative valuation method.

How does HQH's valuation metrics compare to the industry average?

The average P/S ratio for HQH's competitors is 0.00, providing a benchmark for relative valuation. abrdn Healthcare Investors Corp (HQH) exhibits a P/S ratio of --, which is 0% above the industry average. Given its robust revenue growth of 0%, this premium appears unsustainable.

What is the current P/B ratio for abrdn Healthcare Investors (HQH) as of Mar 22 2026?

As of Mar 22 2026, abrdn Healthcare Investors (HQH) has a P/B ratio of 0.77. This indicates that the market values HQH at 0.77 times its book value.

What is the current FCF Yield for abrdn Healthcare Investors (HQH) as of Mar 22 2026?

As of Mar 22 2026, abrdn Healthcare Investors (HQH) has a FCF Yield of 0.00%. This means that for every dollar of abrdn Healthcare Investors's market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for abrdn Healthcare Investors (HQH) as of Mar 22 2026?

As of Mar 22 2026, abrdn Healthcare Investors (HQH) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of abrdn Healthcare Investors's expected earnings over the next 12 months.

What is the current Forward P/S ratio for abrdn Healthcare Investors (HQH) as of Mar 22 2026?

As of Mar 22 2026, abrdn Healthcare Investors (HQH) has a Forward P/S ratio of 0.00. This means the market is valuing HQH at $0.00 for every dollar of expected revenue over the next 12 months.

HQH Valuation